MLTX
MoonLake Immunotherapeutics
$14.79
+$0.72(+5.12%)
54
Overall
60
Value
54
Tech
50
Quality
Market Cap
$672.08M
Volume
2.51M
52W Range
$5.95 - $62.75
Target Price
$14.61
EPS Estimates Overview
| Current Quarter | $-0.97 | Next Quarter | $-0.68 |
| Current Year | $-3.51 | Next Year | $-3.56 |
| QoQ Growth | +29.9% | YoY Growth | -1.4% |
| 3Y EPS CAGR | +0.0% | Target Price | $14.61 |
| Consensus | Buy | Upside | -1.2% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MLTX | $14.79 | +5.1% | 2.51M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get MoonLake Immunotherapeutics Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW